Other Events ·
On August 31, 2026, Arcadia Biosciences received a notification from Nasdaq that its stockholders' equity of $633,000…
RKDAArcadia Biosciences, Inc.
On August 31, 2026, Arcadia Biosciences received a notification from Nasdaq that its stockholders' equity of $633,000 as of June 30, 2026, failed to meet the minimum requirement of $2,500,000 under Listing Rule 5550(b)(1). The company has until October 15, 2026, to submit a compliance plan and may request an extension of up to 180 days. Failure to regain compliance could result in delisting from the Nasdaq Capital Market. Arcadia Biosciences operates in the agricultural biotechnology industry, developing crop traits and technologies.